Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Ionis Pharmaceuticals, Inc. (IONS) had Debt to Capital Ratio of 0.49 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$156.72M |
|
$-128.61M |
|
$2.34M |
|
$154.38M |
|
$316.90M |
|
$-160.18M |
|
$31.79M |
|
$-128.39M |
|
$-158.30M |
|
$-128.61M |
|
$-128.61M |
|
$-128.61M |
|
$-158.46M |
|
$-160.18M |
|
$-159.11M |
|
159.76M |
|
159.76M |
|
$-0.80 |
|
$-0.80 |
|
| Balance Sheet Financials | |
$2.52B |
|
$106.12M |
|
$514.10M |
|
$3.03B |
|
$903.46M |
|
$595.91M |
|
$1.51B |
|
$2.42B |
|
$617.97M |
|
$617.97M |
|
$617.97M |
|
161.14M |
|
| Cash Flow Statement Financials | |
$-130.87M |
|
$141.73M |
|
$84.66M |
|
$242.08M |
|
$338.34M |
|
$96.26M |
|
$90.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.79 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.49 |
1.99 |
|
98.51% |
|
-102.21% |
|
-102.21% |
|
-- |
|
-81.93% |
|
-82.06% |
|
$-161.03M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.22 |
|
6.37 |
|
14.13 |
|
-20.81% |
|
-20.81% |
|
-4.24% |
|
-10.59% |
|
$3.83 |
|
$-1.01 |
|
$-0.82 |
|